MRSA

Feature Article

Evidence-Based Care for <i>S aureus</i> Infection Improves Survival

Evidence-Based Care for S aureus Infection Improves Survival

Increase use of evidence-based care processes decreased mortality associated with S aureus bacteremia in VHA hospitals.

Latest News

Staphylococcus aureus in Patients Diagnosed With Bronchiectasis Without Cystic Fibrosis

Staphylococcus aureus in Patients Diagnosed With Bronchiectasis Without Cystic Fibrosis

In an attempt to determine if the presence of S aureus could be used as a marker for more severe disease, investigators assessed the relationship between S aureus-positive bronchiectasis infection and pulmonary function, frequency of exacerbations, and hospital admissions.

Treatment for MRSA Complicated Bacteremia and Infective Endocarditis

Treatment for MRSA Complicated Bacteremia and Infective Endocarditis

Further studies are warranted to assess the efficacy and safety of fosfomycin plus imipenem against methicillin-resistant Staphylococcus aureus complicated infections.

Antibiotic Stewardship: Role of MRSA Nasal Screening

Antibiotic Stewardship: Role of MRSA Nasal Screening

MRSA nares screening can be a stewardship tool to streamline empiric antibiotic therapy among those not nares colonized with MRSA.

Telavancin Efficacy Against Difficult-to-Treat Pathogens

Telavancin Efficacy Against Difficult-to-Treat Pathogens

Theravance Biopharma announced positive results from 3 studies on Vibativ (telavancin), a lipoglycopeptide antibiotic.

VA: MRSA Infection Rates on the Decline

VA: MRSA Infection Rates on the Decline

Researchers found that, over 8 years, MRSA health care-associated infection rates significantly declined.

Prophages Can Prevent Invasiveness of S aureus Growth in Diabetic Foot Ulcers

Prophages Can Prevent Invasiveness of S aureus Growth in Diabetic Foot Ulcers

The use of prophages can reduce invasiveness in S aureus infections of diabetic foot ulcers that limit intracellular growth.

Risk of S. aureus Bacteremia Increased in Patients on Glucocorticoids

Risk of S. aureus Bacteremia Increased in Patients on Glucocorticoids

Community-acquired Staphylococcus aureus bacteremia risk rose along with the dosage.

Is MRSA Incidence in Pediatric Populations Changing?

Is MRSA Incidence in Pediatric Populations Changing?

During study period, decrease noted in S. aureus susceptibility to clindamycin.

Community-Acquired Staph Bacteremia More Common in Diabetes Patients?

Community-Acquired Staph Bacteremia More Common in Diabetes Patients?

Risk up seven-fold among patients with type 1 diabetes, almost three-fold for those with type 2.

Trimethoprim-Sulfamethoxazole Better Than Placebo for Abscess

Trimethoprim-Sulfamethoxazole Better Than Placebo for Abscess

Higher clinical cure rate compared with placebo in setting in which MRSA was prevalent.

Sign Up for Free e-newsletters